Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gehan Botrus
Observed names:
Botrus G,
G Botrus,
G. Botrus
Institution:
Winship Cancer Institute
Observed institutions:
The University of Texas MD Anderson Cancer Center,
Loma Linda University,
Mayo Clinic in Arizona,
Mayo Clinic Hospital,
Winship Cancer Institute,
Mayo Clinic Comprehensive Cancer Center (Arizona),
Texas Tech University Health Sciences Center,
KU Leuven
show all 8
ORCID:
0000-0002-9968-892X
Observed ORCID:
0000-0002-9968-892X
OpenAlex ID:
A5103148302
Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma
2017
·
Manal M. Hassan
, Gehan Botrus
, et al.
·
Clinical Gastroenterology and Hepatology
·
140
Disparities in breast cancer: a multi‐institutional comparative analysis focusing on American Hispanics
2018
·
Zeina Nahleh
, Salman Otoukesh
, et al.
·
Cancer Medicine
·
36
PDF
Bevacizumab in the neoadjuvant treatment of human epidermal growth factor receptor 2‑negative breast cancer: A meta‑analysis of randomized controlled trials
2019
·
Zeina Nahleh
, Gehan Botrus
, et al.
·
Molecular and Clinical Oncology
·
19
PDF
Proteomics in cancer research: Methods and application of array-based protein profiling technologies
2005
·
Ann Hoeben
, Bart Landuyt
, et al.
·
Analytica Chimica Acta
·
15
Clinico-pathologic disparities of breast cancer in Hispanic/Latina women
2018
·
Z. Nahleh
, G. Botrus
, et al.
·
Breast Disease
·
11
Natural History of T1N0M0 Hepatocellular carcinoma: Large scale study in the United States.
2015
·
Humaid Obaid Al-Shamsi
, Reham Abdel-Wahab
, et al.
·
Journal of Clinical Oncology
·
6
Disparities in Metabolic Conditions and Cancer Characteristics among Hispanic Women with Breast Cancer: A Multi-Institutional Study
2022
·
Iktej S. Jabbal
, Alok Dwivedi
, et al.
·
Cancers
·
3
PDF
A meta-analysis of randomzied controlled trials comparing the effect of neoadjuvant chemotherapy with or without bevacizumab (Bev) in the treatment of breast cancer (BC).
2016
·
Zeina A. Nahleh
, Christopher Dodoo
, et al.
·
Journal of Clinical Oncology
·
3
Abstract 3594: Impact of metformin on HCC prognosis
2012
·
Khan Akmal
, Hesham Hassabo
, et al.
·
Cancer Research
·
2
Investigation into the immune microenvironment of gastroenteropancreatic high-grade neuroendocrine carcinoma.
2023
·
Andrew Jacob McDonald
, Gabriela Oprea
, et al.
·
Journal of Clinical Oncology
·
1
Abstract P6-10-04: “Disparities in breast cancer: A multi-institutional comparative analysis focusing on American Hispanics”
2018
·
S Otoukesh
, Z Nahleh
, et al.
·
Cancer Research
·
1
The protective effect of hormonal intake on risk of hepatocellular carcinoma in the United States.
2015
·
Gehan Botrus
, Ahmed S Shalaby
, et al.
·
Journal of Clinical Oncology
·
1
Hepatitis B- and C-associated hepatocellular carcinoma in a large U.S. cancer center: Do clinicopathologic features or patient outcomes differ by the potentially causative viruses?
2015
·
Marc Isamu Uemura
, Ahmed Omar Kaseb
, et al.
·
Journal of Clinical Oncology
·
1
Identifying opportunities to improve equity in breast cancer care for uninsured Hispanic patients in underserved communities.
2021
·
Gehan Botrus
, Natalie Ertz -Archambault
, et al.
·
Journal of Clinical Oncology
Comparison of care process for newly diagnosed breast cancer in insured versus uninsured populations: Opportunities for improving health equity.
2021
·
Gehan Botrus
, Natalie Ertz-Archambault
, et al.
·
Journal of Clinical Oncology
Prognostic significance of periostin in patients with hepatocellular carcinoma.
2018
·
Ahmed Omar Kaseb
, Yehia I. Abugabal
, et al.
·
Journal of Clinical Oncology
Disparity in Metabolic Conditions among Hispanic/Latina Women with Breast Cancer
2018
·
Joh D
, Botrus G
, et al.
·
Annals of Behavioural Science
PDF
Rate of breast conserving surgery versus mastectomy in Hispanic/Latina women with breast cancer in El Paso, TX.
2016
·
Gehan Botrus
, Alok kumar Dwivedi
, et al.
·
Journal of Clinical Oncology
The protective effect of physical activity on risk of hepatocellular carcinoma in USA.
2016
·
Ahmed S Shalaby
, Gehan Botrus
, et al.
·
Journal of Clinical Oncology
Andexanet as a New Factor Xa Inhibitor Antidote: A Review of the Literature and Future Perspectives
2016
·
Kevin Salire
, Gehan Botrus
, et al.
·
Medical Science Review
Natural history of T1N0M0 hepatocellular carcinoma: Large scale study in the United States.
2016
·
Humaid Obaid Al-Shamsi
, Reham Abdel-Wahab
, et al.
·
Journal of Clinical Oncology
Single institutional experience of bevacizumab-based regimens in treatment of hepatocellular carcinoma.
2015
·
Reham Abdel-Wahab
, Manal Hassan
, et al.
·
Journal of Clinical Oncology
Predictors of missed appointments by international patients (IntlPts) in the International Assessment Center (IAC) at MD Anderson Cancer Center (MDACC).
2015
·
Renato Lenzi
, Gehan Botrus
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
23
Citation count:
239
H-index:
6
I10-index:
5
Year
Topic
Type